A new HIV/AIDS vaccine, developed by Chinese scientists, has completed its safety testing stage, the results of which will soon be submitted to the Chinese authorities, experts said during the 2014 National Conference on HIV/AIDS held in Beijing on Tuesday. Shao Yiming, AIDS expert at the Chinese Center for Disease Control and Prevention, told the Global Times that the vaccine has finished preliminary safety testing, and the drug will now move on to tests of its effectiveness. “We are currently analyzing the data from the safety tests, and the results will be sent to the China Food and Drug Administration before the team carries out effectiveness tests,” Shao said. The vaccine will be tested until 2018 at least. The drug is planned to be a HIV/AIDS vaccine, but hopefully after further development it could be used to treat HIV/AIDS carriers, Shao said. Between January and August this year, 70,000 new HIV/AIDS patients were identified...
đź”’ Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




